Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | 3L7R886Y06 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Hepatitis A virus cellular receptor 2 inhibitor | PubMed ClinicalTrials Other |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Myelodysplastic Syndromes | 3 | D009190 | ClinicalTrials |
Leukemia, Myelomonocytic, Chronic | 3 | D015477 | ClinicalTrials |
Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Glioblastoma | 1 | D005909 | ClinicalTrials |
Primary Myelofibrosis | 1 | D055728 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4594575 |
FDA SRS | 3L7R886Y06 |